Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report17 September 2020
Urenco welcomes the draft agreement by the US Department of Commerce (DOC) and Rosatom on the level of uranium imports into the US from 2021-2040.
The need for a revised ‘Suspension Agreement’ was highlighted by the conclusions of the Nuclear Fuel Working Group and US DOC’s post-preliminary analysis in the Administrative Review of the current agreement.
The DOC has taken into account the diverse concerns of US stakeholders to produce a balanced solution, which will help support domestic enrichment capacity and reinvestment in that capacity.
Urenco’s New Mexico facility, UUSA, operated by Louisiana Energy Services, is a domestic supplier of enrichment services in the US. Our involvement in the US uranium market is in the best interests of our customers to ensure a reliable, transparent and timely supply of nuclear fuel to US reactors.
In 2008, the Domenici Amendment codified the current Suspension Agreement into US law. Since there is a termination clause in the new Suspension Agreement, LES would support a similar codification into US law to ensure that it lasts until 2040.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries